<?xml version="1.0" encoding="UTF-8"?>
<ref id="B254">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>G.</given-names>
   </name>
  </person-group> (
  <year>2020a</year>). 
  <article-title>Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.</article-title>
  <source>
   <italic>Int. J. Antimicrob. Agents</italic>
  </source>
  <volume>55</volume>:
  <issue>105954</issue>. 
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105954</pub-id>
  <?supplied-pmid 32234467?>
  <pub-id pub-id-type="pmid">32234467</pub-id>
 </mixed-citation>
</ref>
